Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Brigham and Women's Hospital
City of Hope Medical Center
Joint Authority for Päijät-Häme Social and Health Care
University of California, San Francisco
National Cancer Institute (NCI)
Massachusetts General Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
City of Hope Medical Center
Mayo Clinic
Corewell Health East
King's College London
Shirley Ryan AbilityLab
VCS Foundation
UNC Lineberger Comprehensive Cancer Center
University of Maryland, Baltimore
Chang Gung Memorial Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Rochester
Icahn School of Medicine at Mount Sinai
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Boston Scientific Corporation
Istituto Oncologico Veneto IRCCS
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Beth Israel Deaconess Medical Center
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center